CRVSCorvus Pharmaceuticals, Inc.

$14.74

Is the business good?

How good a business is CRVS?

Share count, year on year
+19%

Share count, year on year · shareholders own a smaller slice than a year ago

Details
Free cash flow, trailing twelve months
−$45M
Net income, trailing twelve months
−$54M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.